大動脈腸骨閉塞性疾患（腸骨疾患）治療の世界市場：市場規模・シェア・動向分析 (機器の種類別・処置別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

大動脈腸骨閉塞性疾患治療市場の概要

世界の大動脈腸骨閉塞性疾患（腸骨疾患）治療の市場規模は、2024年に21億5,000万米ドルと推計され、2025年から2030年にかけてCAGR 5.5%で成長し、2030年には29億5,000万米ドルに達すると予測されます。大動脈閉塞性疾患（AIOD）は、腹部と骨盤内の大動脈、特に大動脈と腸骨動脈が狭窄または閉塞し、脚への血流が減少する疾患です。

末梢動脈疾患（PAD）の有病率の増加は、市場の成長を促進する重要な要因の一つです。2023年6月に発表された米国心臓協会（American Heart Association, Inc.）の記事によると、末梢動脈疾患（PAD）は世界中で推定2億人が罹患しています。大動脈閉塞性疾患（AIOD）の開発に大きく寄与しています。高齢化、糖尿病、喫煙などの要因によってPADの有病率が増加しているため、AIODに対する効果的な治療の必要性が高まっています。この需要の高まりが、腸骨動脈ステント留置術や血管内治療などの低侵襲手技の採用を後押しし、適切な血流を回復させ、脚の痛みや運動制限などの症状を緩和するのに役立っています。

政府のイニシアチブの高まりが市場成長の原動力2023年6月に発表されたCongress.Govの記事によると、米国政府は動脈・静脈包括的（ARC）法の導入を通じて、大動脈閉塞性疾患の主な原因である末梢動脈疾患（PAD）の早期発見と管理の強化に向けて重要な一歩を踏み出しました。この法律は社会保障法の改正を提案するもので、高リスクと認定されたメディケアおよびメディケイドの受給者が、自己負担なしでPAD検診を受けられるようにすることを目的としています。対象となる診断法には、足関節上腕血圧比（ABI）検査と動脈デュプレックススキャンが含まれ、PADを特定し、大動脈-腸骨領域の疾患の重症度を評価するために重要です。2024年から2028年まで毎年600万米ドルの資金を認可するARC法は、早期診断と時宜を得た介入を改善し、進行した閉塞性疾患の負担を軽減し、腸骨ステント留置術や血行再建療法などの標的治療オプションの需要を高める可能性を追求しています。このイニシアチブは予防医療を促進し、必要不可欠な血管医療サービスへの幅広いアクセスを支援するものです。

さらに、米国心臓病学会（American College of Cardiology Foundation）が2025年2月に発表した論文によれば2025年2月に発表された記事によると、最近再提出されたSustainable Cardiopulmonary Rehabilitation Services in the Home Act（H.R. 783）は、在宅心肺リハビリテーションサービスのメディケア適用を恒久化することを提案しています。この立法措置は、特に移動に制限のある患者や遠隔地に居住する患者にとって、必要不可欠なリハビリテーションへのアクセスを強化するためのものです。リハビリテーション治療へのアクセスを容易にするこの構想は、末梢動脈疾患（PAD）および大動脈閉塞性疾患を含む関連疾患の効果的な管理をサポートし、最終的に患者の転帰を改善し、市場における高度な治療オプションの需要を促進します。

大動脈腸骨閉塞性疾患（腸骨疾患）治療における技術的進歩が市場の成長を促進します。例えば、2025年1月、Bentley Medical社はLeipzig Interventional Course（LINC）2025でBeFlow腸骨カバーステントシステムを発表し、大動脈-腸骨閉塞性疾患の治療における大きな進歩を示しました。複雑な腸骨病変に対応するよう設計されたBeFlowステントは、長期開存性と耐久性が向上し、重度に狭窄または閉塞した腸骨動脈にカバードステントを推奨する欧州血管外科学会のガイドラインに沿ったものとなっています。直径7～10mm、長さ37～57mmで利用可能なBeFlowステントは、ベアメタルステントに代わる費用効果の高いステントを提供し、高度な血管インターベンションへの患者のアクセスを改善することを目的としています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 世界の大動脈腸骨閉塞性疾患（腸骨疾患）治療市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• 大動脈腸骨閉塞性疾患（腸骨疾患）治療市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析

第4章 大動脈腸骨閉塞性疾患（腸骨疾患）治療市場：機器の種類別の推定・動向分析

• 大動脈腸骨閉塞性疾患（腸骨疾患）治療市場：ダッシュボード、機器の種類別
• 大動脈腸骨閉塞性疾患（腸骨疾患）治療市場：変動分析、機器の種類別
• 大動脈腸骨閉塞性疾患（腸骨疾患）治療の市場規模の予測と動向分析：機器の種類別（2018～2030年）
• 血管内デバイス
• 外科用機器

第5章 大動脈腸骨閉塞性疾患（腸骨疾患）治療市場：処置別の推定・動向分析

• 大動脈腸骨閉塞性疾患（腸骨疾患）治療市場：ダッシュボード、処置別
• 大動脈腸骨閉塞性疾患（腸骨疾患）治療市場：変動分析、処置別
• 大動脈腸骨閉塞性疾患（腸骨疾患）治療の市場規模の予測と動向分析：処置別（2018～2030年）
• 血管内手術
• ハイブリッド手術
• 開腹手術

第6章 大動脈腸骨閉塞性疾患（腸骨疾患）治療市場：最終用途別の推定・動向分析

• 大動脈腸骨閉塞性疾患（腸骨疾患）治療市場：ダッシュボード、最終用途別
• 大動脈腸骨閉塞性疾患（腸骨疾患）治療市場：変動分析、最終用途別
• 大動脈腸骨閉塞性疾患（腸骨疾患）治療の市場規模の予測と動向分析：最終用途別（2018～2030年）
• 病院
• 外来施設
• その他

第7章 大動脈腸骨閉塞性疾患（腸骨疾患）治療市場：地域別の推定・動向分析（国別、機器の種類別、処置別、最終用途別）

• 世界の大動脈腸骨閉塞性疾患（腸骨疾患）治療市場：ダッシュボード、地域別
• 市場規模の予測と動向分析（2018年～2030年）
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • スウェーデン
  • ノルウェー
  • デンマーク
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 最近の動向と影響分析：主要メーカー別
• 企業/競合の分類
• ベンダー情勢
  • 主要販売代理店およびチャネルパートナーのリスト
  • 主要顧客
  • 主要企業の分析（2024年）
  • BD.
  • Bentley InnoMed
  • Scitech Medical
  • Abbott
  • Boston Scientific Corporation
  • WL Gore &Associates, Inc.
  • Medtronic
  • Cook
  • Terumo Corporation
  • iVascular
  • Getinge AB
  • Biotronik SE &Co KG

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 4 Global aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 5 Global aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030
• Table 6 Global aorto-iliac occlusive disease (iliac disease) treatment market, by region, 2018 - 2030 (USD Million)
• Table 7 North America aorto-iliac occlusive disease (iliac disease) treatment market, by country, 2018 - 2030 (USD Million)
• Table 8 North America aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 9 North America aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 10 North America aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 11 U.S. aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 12 U.S. aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 13 U.S. aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 14 Canada aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 15 Canada aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 16 Canada aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 17 Mexico aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 18 Mexico aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 19 Mexico aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 20 Europe aorto-iliac occlusive disease (iliac disease) treatment market, by country, 2018 - 2030 (USD Million)
• Table 21 Europe aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 22 Europe aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 23 Europe aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 24 UK aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 25 UK aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 26 UK aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 27 Germany aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 28 Germany aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 29 Germany aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 30 France aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 31 France aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 32 France aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 33 Italy aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 34 Italy aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 35 Italy aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 36 Spain aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 37 Spain aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 38 Spain aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 39 Denmark aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 40 Denmark aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 41 Denmark aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 42 Sweden aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 43 Sweden aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 44 Sweden aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 45 Norway aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 46 Norway aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 47 Norway aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific aorto-iliac occlusive disease (iliac disease) treatment market, by country, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 51 Asia Pacific aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 52 Japan aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 53 Japan aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 54 Japan aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 55 China aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 56 China aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 57 China aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 58 India aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 59 India aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 60 India aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 61 Australia aorto-iliac occlusive disease (iliac disease) treatment market, by country, 2018 - 2030 (USD Million)
• Table 62 Australia aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 63 Australia aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 64 Australia aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 65 Thailand aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 66 Thailand aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 67 Thailand aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 68 South Korea aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 69 South Korea aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 70 South Korea aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 71 Latin America aorto-iliac occlusive disease (iliac disease) treatment market, by country, 2018 - 2030 (USD Million)
• Table 72 Latin America aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 73 Latin America aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 74 Latin America aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 75 Brazil aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 76 Brazil aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 77 Brazil aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 78 Argentina aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 79 Argentina aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 80 Argentina aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 81 MEA aorto-iliac occlusive disease (iliac disease) treatment market, by country, 2018 - 2030 (USD Million)
• Table 82 MEA aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 83 MEA aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 84 MEA aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 85 South Africa aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 86 South Africa aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 87 South Africa aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 89 Saudi Arabia aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 90 Saudi Arabia aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 91 UAE aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 92 UAE aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 93 UAE aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 94 Kuwait aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
• Table 95 Kuwait aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
• Table 96 Kuwait aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
• Table 97 Participant's overview
• Table 98 Financial performance
• Table 99 Key companies undergoing expansions
• Table 100 Key companies undergoing acquisitions
• Table 101 Key companies undergoing collaborations
• Table 102 Key companies launching new products
• Table 103 Key companies undergoing partnerships
• Table 104 Key companies undertaking other strategies

List of Figures

• Fig. 1 Aorto-iliac occlusive disease (iliac disease) treatment market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Aorto-iliac occlusive disease (iliac disease) treatment market revenues, 2024 (USD Millions)
• Fig. 9 Market driver relevance analysis (Current & future impact)
• Fig. 10 Market restraint relevance analysis (Current & future impact)
• Fig. 11 Porter's five forces analysis
• Fig. 12 PESTLE analysis
• Fig. 13 Aorto-iliac occlusive disease (iliac disease) treatment market Device type outlook:
• Fig. 14 Aorto-iliac occlusive disease (iliac disease) treatment market: Device type movement analysis
• Fig. 15 Segment dashboard
• Fig. 16 Global endovascular devices market, 2018 - 2030 (USD Million)
• Fig. 17 Global balloon angioplasty devices market, 2018 - 2030 (USD Million)
• Fig. 18 Global atherectomy systems market, 2018 - 2030 (USD Million)
• Fig. 19 Global stents market, 2018 - 2030 (USD Million)
• Fig. 20 Global self-expanding stents market, 2018 - 2030 (USD Million)
• Fig. 21 Global balloon-expandable stents market, 2018 - 2030 (USD Million)
• Fig. 22 Global covered stent grafts market, 2018 - 2030 (USD Million)
• Fig. 23 Global bifurcated aortic stent grafts market, 2018 - 2030 (USD Million)
• Fig. 24 Global surgical devices market, 2018 - 2030 (USD Million)
• Fig. 25 Aorto-iliac occlusive disease (iliac disease) treatment market Procedure outlook:
• Fig. 26 Aorto-iliac occlusive disease (iliac disease) treatment market: Procedure movement analysis
• Fig. 27 Global endovascular procedures market, 2018 - 2030 (USD Million)
• Fig. 28 Global balloon angioplasty market, 2018 - 2030 (USD Million)
• Fig. 29 Global primary stenting market, 2018 - 2030 (USD Million)
• Fig. 30 Global kissing stents market, 2018 - 2030 (USD Million)
• Fig. 31 Global covered stent grafts market, 2018 - 2030 (USD Million)
• Fig. 32 Global endovascular aortic repair (EVAR) market, 2018 - 2030 (USD Million)
• Fig. 33 Global hybrid procedures market, 2018 - 2030 (USD Million)
• Fig. 34 Global open surgical procedures market, 2018 - 2030 (USD Million)
• Fig. 35 Aorto-iliac occlusive disease (iliac disease) treatment market End use outlook:
• Fig. 36 Aorto-iliac occlusive disease (iliac disease) treatment market: End use movement analysis
• Fig. 37 Global hospitals market, 2018 - 2030 (USD Million)
• Fig. 38 Global outpatient facilities market, 2018 - 2030 (USD Million)
• Fig. 39 Global others market, 2018 - 2030 (USD Million)
• Fig. 40 Regional market place: Key takeaways
• Fig. 41 North America aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 42 U.S. aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 43 Canada aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 44 Mexico aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 45 Europe aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 46 Germany aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 47 UK aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 48 France aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 49 Italy aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 50 Spain aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 51 Asia Pacific aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 52 Japan aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 53 China aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 54 India aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 55 Australia aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 56 Latin America aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 57 Brazil aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 58 MEA aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 59 South Africa aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 60 Saudi Arabia aorto-iliac occlusive disease (iliac disease) treatment market, 2018 - 2030 (USD Million)
• Fig. 61 Market Participant Categorization
• Fig. 62 Strategy mapping

Aorto-Iliac Occlusive Disease Treatment Market Summary

The global aorto-iliac occlusive disease (iliac disease) treatment market size was estimated at USD 2.15 billion in 2024 and is projected to reach USD 2.95 billion by 2030, growing at a CAGR of 5.5% from 2025 to 2030. Aorto-Iliac Occlusive Disease (AIOD) is a condition where the large arteries in the abdomen and pelvis, specifically the aorta and iliac arteries, become narrowed or blocked, reducing blood flow to the legs.

The increasing prevalence of Peripheral Artery Disease (PAD) is one of the key factors driving the market's growth. According to the American Heart Association, Inc. article published in June 2023, Peripheral artery disease (PAD) affects an estimated 200 million people worldwide. It significantly contributes to developing Aorto-Iliac Occlusive Disease (AIOD). The growing prevalence of PAD, driven by factors such as aging populations, diabetes, and smoking, has increased the need for effective treatments for AIOD. This rising demand drives the adoption of minimally invasive procedures, including iliac artery stenting and endovascular therapies, which help restore proper blood flow and alleviate symptoms like leg pain and limited mobility.

Increasing government initiatives drive the market growth. According to the Congress.Gov article published in June 2023, the U.S. government took a significant step toward enhancing early detection and management of Peripheral Artery Disease (PAD), a primary contributor to Aorto-Iliac Occlusive Disease, through the introduction of the Arterial and Venous Comprehensive (ARC) Act. This legislation proposes amendments to the Social Security Act, aiming to ensure that Medicare and Medicaid beneficiaries identified as high-risk can access PAD screening without incurring out-of-pocket costs. Covered diagnostic procedures include ankle-brachial index (ABI) tests and arterial duplex scans, critical for identifying PAD and assessing disease severity in the aorto-iliac region. Authorizing USD 6 million in annual funding from 2024 to 2028, the ARC Act seeks to improve early diagnosis and timely intervention, potentially reducing the burden of advanced occlusive conditions and boosting the demand for targeted treatment options such as iliac stenting and revascularization therapies. This initiative promotes preventive care and supports broader access to essential vascular health services.

Moreover, as per the American College of Cardiology Foundation. Article published in February 2025, the Sustainable Cardiopulmonary Rehabilitation Services in the Home Act (H.R. 783), recently reintroduced, proposes to make the Medicare coverage for in-home cardiopulmonary rehabilitation services permanent. This legislative move is designed to enhance access to essential rehabilitation, especially for patients with mobility limitations or those residing in remote areas. Facilitating easier access to rehabilitation care, this initiative supports the effective management of peripheral artery disease (PAD) and related conditions, including Aorto-Iliac Occlusive Disease, ultimately improving patient outcomes and driving demand for advanced treatment options in the market.

Technological advancements in aorto-iliac occlusive disease (iliac disease) treatment drive the market's growth. For instance, in January 2025, Bentley Medical introduced the BeFlow iliac covered stent system at the Leipzig Interventional Course (LINC) 2025, marking a significant advancement in treating aorto-iliac occlusive disease. Designed to address complex iliac lesions, the BeFlow stent offers enhanced long-term patency and durability, aligning with European Society for Vascular Surgery guidelines that recommend covered stents for heavily stenosed or occluded iliac arteries. Available in diameters ranging from 7 to 10 mm and lengths of 37 and 57 mm, the BeFlow stent aims to provide a cost-effective alternative to bare metal stents, improving patient access to advanced vascular interventions.

Global Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and analyzes the industry trends in each sub-segment from 2018 to 2030. For this study, Grand View Research has segmented the global aorto-iliac occlusive disease treatment market report based on device type, procedure, end use, and region:

• Device Type Outlook (Revenue, USD Million, 2018 - 2030)
• Endovascular Devices
  • Balloon Angioplasty Devices
  • Atherectomy Systems
  • Stents
  • Self-Expanding Stents
  • Balloon-Expandable Stents
  • Covered Stent Grafts
  • Bifurcated Aortic Stent Grafts
• Surgical Devices
• Procedure Outlook (Revenue, USD Million, 2018 - 2030)
• Endovascular Procedures
  • Balloon Angioplasty
  • Primary Stenting
  • Kissing Stents
  • Covered Stent Grafts
  • Endovascular Aortic Repair (EVAR)
• Hybrid Procedures
• Open Surgical Procedures
• Procedure Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Outpatient Facilities
• Others
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Device Type
  • 1.2.2. Procedure
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecast timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity price analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Device Type Segment
  • 2.2.2. Procedure Segment
  • 2.2.3. End Use Segment
  • 2.2.4. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Global Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of PAD
    • 3.2.1.2. Rising government initiatives
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost associated with the devices and procedures
    • 3.2.2.2. Lack of awareness and early diagnosis in rural regions
• 3.3. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Device Type Estimates & Trend Analysis

• 4.1. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Device Type Dashboard
• 4.2. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Device Type Movement Analysis
• 4.3. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Size & Forecasts and Trend Analysis, by Device Type, 2018 to 2030 (USD Million)
• 4.4. Endovascular Devices
  • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.4.2. Balloon Angioplasty Devices Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.4.3. Atherectomy Systems Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.4.4. Stents Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.4.2. Self-Expanding Stents
      • 4.4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.4.3. Balloon-Expandable Stents
      • 4.4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.4.4. Covered Stent Grafts
      • 4.4.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.4.5. Bifurcated Aortic Stent Grafts
      • 4.4.4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Surgical Devices
  • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Procedure Estimates & Trend Analysis

• 5.1. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Procedure Dashboard
• 5.2. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Procedure Movement Analysis
• 5.3. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Size & Forecasts and Trend Analysis, by Procedure, 2018 to 2030 (USD Million)
• 5.4. Endovascular Procedures
  • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.4.2. Balloon Angioplasty Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.4.3. Primary Stenting Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.4.4. Kissing Stents Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.4.5. Covered Stent Grafts Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.4.6. Endovascular Aortic Repair (EVAR) Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. Hybrid Procedures
  • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.6. Open Surgical Procedures
  • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: End Use Estimates & Trend Analysis

• 6.1. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: End Use Dashboard
• 6.2. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: End Use Movement Analysis
• 6.3. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Size & Forecasts and Trend Analysis, by End Use , 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.5. Outpatient Facilities
  • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Regional Estimates & Trend Analysis by Country, Device Type, Procedure & End Use

• 7.1. Global Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Regional Dashboard
• 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Regulatory framework/ reimbursement structure
    • 7.3.4.3. Competitive scenario
    • 7.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.8. Norway
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4.9. Denmark
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Regulatory framework/ reimbursement structure
    • 7.4.9.3. Competitive scenario
    • 7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.3. Japan
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.5. Australia
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.7. South Korea
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework/ reimbursement structure
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.3. South Africa
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework/ reimbursement structure
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company analysis, 2024
  • 8.3.4. BD.
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Bentley InnoMed
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Scitech Medical
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Abbott
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Boston Scientific Corporation
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. W. L. Gore & Associates, Inc.
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Medtronic
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Cook
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Terumo Corporation
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. iVascular
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. Getinge AB
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives
  • 8.3.15. Biotronik SE & Co KG
    • 8.3.15.1. Company overview
    • 8.3.15.2. Financial performance
    • 8.3.15.3. Product benchmarking
    • 8.3.15.4. Strategic initiatives